Health Catalyst, Inc.

NasdaqGS:HCAT Voorraadrapport

Marktkapitalisatie: US$494.7m

Health Catalyst Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

Health Catalyst heeft een totaal eigen vermogen van $355.0M en een totale schuld van $345.0M, wat de schuld-eigenvermogensverhouding op 97.2% brengt. De totale activa en totale passiva bedragen respectievelijk $813.1M en $458.0M.

Belangrijke informatie

97.2%

Verhouding schuld/eigen vermogen

US$345.03m

Schuld

Rente dekkingsration/a
ContantUS$387.26m
AandelenUS$355.04m
Totaal verplichtingenUS$458.01m
Totaal activaUS$813.05m

Recente financiële gezondheidsupdates

Recent updates

Health Catalyst: Still Optimistic On Achieving Adjusted EBITDA Targets

Sep 24

Health Catalyst, Inc.'s (NASDAQ:HCAT) Shares Lagging The Industry But So Is The Business

Jul 17
Health Catalyst, Inc.'s (NASDAQ:HCAT) Shares Lagging The Industry But So Is The Business

Health Catalyst: Stellar Earnings Growth Projected

Jun 26

Health Catalyst, Inc. (NASDAQ:HCAT) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

May 12
Health Catalyst, Inc. (NASDAQ:HCAT) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Benign Growth For Health Catalyst, Inc. (NASDAQ:HCAT) Underpins Its Share Price

Apr 04
Benign Growth For Health Catalyst, Inc. (NASDAQ:HCAT) Underpins Its Share Price

Health Catalyst: Achieving FY28 Long-Term Guidance Is Possible

Mar 09

Health Catalyst Looks To Slim Down As It Faces Industry Headwinds (Downgrade)

Feb 16

Is Health Catalyst (NASDAQ:HCAT) A Risky Investment?

Jan 27
Is Health Catalyst (NASDAQ:HCAT) A Risky Investment?

What Health Catalyst, Inc.'s (NASDAQ:HCAT) 25% Share Price Gain Is Not Telling You

Dec 24
What Health Catalyst, Inc.'s (NASDAQ:HCAT) 25% Share Price Gain Is Not Telling You

Is Health Catalyst, Inc. (NASDAQ:HCAT) Trading At A 47% Discount?

Dec 15
Is Health Catalyst, Inc. (NASDAQ:HCAT) Trading At A 47% Discount?

Is Health Catalyst (NASDAQ:HCAT) Weighed On By Its Debt Load?

Oct 24
Is Health Catalyst (NASDAQ:HCAT) Weighed On By Its Debt Load?

Subdued Growth No Barrier To Health Catalyst, Inc.'s (NASDAQ:HCAT) Price

Jul 31
Subdued Growth No Barrier To Health Catalyst, Inc.'s (NASDAQ:HCAT) Price

Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt?

Jun 27
Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt?

Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt?

Feb 22
Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt?

Health Catalyst, Inc. (NASDAQ:HCAT) Shares Could Be 22% Above Their Intrinsic Value Estimate

Dec 06
Health Catalyst, Inc. (NASDAQ:HCAT) Shares Could Be 22% Above Their Intrinsic Value Estimate

Is Health Catalyst (NASDAQ:HCAT) Using Debt In A Risky Way?

Nov 03
Is Health Catalyst (NASDAQ:HCAT) Using Debt In A Risky Way?

Health Catalyst: Looking For A Turnaround For This 'Bio Boom' Candidate

Oct 14

Health Catalyst names Kevin Freeman as Chief Growth Officer, Tarah Bryan as Chief Marketing Officer, Dave Ross as Chief Technology Officer

Sep 07

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( $457.4M ) HCAT } overtreffen de korte termijn passiva ( $323.8M ).

Langlopende schulden: De kortetermijnactiva HCAT ( $457.4M ) overtreffen de langetermijnschulden ( $134.2M ).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: HCAT heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van HCAT is de afgelopen 5 jaar gestegen van 23.2% naar 97.2%.


Balans


Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: HCAT heeft op basis van de huidige vrije kasstroom voldoende cash runway voor meer dan 3 jaar.

Voorspelling contante baan: Er zijn onvoldoende gegevens om te bepalen of HCAT voldoende cash runway heeft als de vrije kasstroom blijft groeien of krimpen op basis van historische percentages.


Ontdek gezonde bedrijven